European Commission Approves the Commercialisation of RYEQO® for the Symptomatic Treatment of Endometriosis ...Middle East

BUDAPEST, Hungary and BASEL, Switzerland and CAMBRIDGE, Mass , Nov. 2, 2023 /PRNewswire/ -- Gedeon Richter Plc. ('Richter') together with Sumitomo Pharma America, Inc. ('SMPA') and Sumitomo Pharma Switzerland, GmbH ('SMPS') today announce that the European Commission ('EC') has granted...

Hence then, the article about european commission approves the commercialisation of ryeqo for the symptomatic treatment of endometriosis was published today ( Thursday 02/11/2023 - 04:28 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( European Commission Approves the Commercialisation of RYEQO® for the Symptomatic Treatment of Endometriosis )

Also on site :

• Suspected mountain lion attack in Colorado mountains under investigation
• Person falls to death on Boylston Street on New Year’s Eve
• Hazel Avenue in Orangevale closed as suspect barricades in home